SCHEMBL7142433

SCHEMBL7142433

CN1Cc2c(C(=O)O)ncn2-c2cccc(Cl)c2C1=O

nearest known ligand 0.74

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 6/20 0.64
GABRG2 P18507 6/20 0.64
GABRB3 P28472 6/20 0.64
GABRA5 P31644 6/20 0.64
GABRA3 P34903 6/20 0.64
GABRA2 P47869 6/20 0.64
GABRA6 Q16445 5/20 0.64
GABRA4 P48169 3/20 0.64
GABRB2 P47870 2/20 0.64
GABRP O00591 1/20 0.64
GABRD O14764 1/20 0.64
GABRB1 P18505 1/20 0.64
GRM5 P41594 1/20 0.64
GABRE P78334 1/20 0.64
GABRG1 Q8N1C3 1/20 0.64
GABRG3 Q99928 1/20 0.64
GABRQ Q9UN88 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Imidazole SCHEMBL10707046 0.90 GABRA1 (0.54) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL4046179 0.90 GABRA1 (0.60) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL9669357 0.89 GABRA1 (0.59) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL7276188 0.88 GABRA1 (0.54) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL7362085 0.87 GABRA1 (0.60) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL8871585 0.87 GABRA1 (0.59) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL11087842 0.86 GABRA1 (0.59) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL11113143 0.86 GABRA1 (0.49) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL7332213 0.86 GABRG2 (0.49) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL7274213 0.86 GABRA1 (0.49) GABRA1GABRG2GABRB3GABRA5GABRA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0059389-B1 IMIDAZODIAZEPINES, PROCESS FOR THEIR PREPARATION AND MEDICINES CONTAINING THEM F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1984-12-12 EP claimed
EP-1202977-B1 PROCESS FOR MANUFACTURING DIAZEPINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2003-12-17 EP disclosed
EP-0672666-B1 Imidazodiazepins HOFFMANN LA ROCHE (CH) 2001-07-25 EP disclosed
EP-0451626-B1 The use of benzodiazepine compounds for preparing a pharmaceutical composition against CNS disorders related to the excitatory aminoacids NEUROSEARCH AS (DK) 1997-09-10 EP disclosed
US-5665718-A ANXIOLYTIC, ANTICONVULSANT, MUSCLE RELAXANT, SEDATIVE, HYPNOTIC AGENTS HOFFMANN-LA ROCHE INC. (US) 1997-09-09 US disclosed
EP-0672666-A2 Imidazodiazepins F. Hoffmann-La Roche AG (CH) 1995-09-20 EP disclosed
EP-0150040-B1 Imidazodiazepine derivatives HOFFMANN LA ROCHE (CH) 1994-08-31 EP disclosed
US-5270306-A Method of antagonizing excitatory amino acids by administration of imidazobenzodiazepine compounds NEUROSEARCH A/S (DK) 1993-12-14 US disclosed
EP-0451626-A2 The use of benzodiazepine compounds for preparing a pharmaceutical composition against CNS disorders related to the excitatory aminoacids NEUROSEARCH A/S (DK) 1991-10-16 EP disclosed
US-4775671-A ANXIOLYTIC AGENTS, ANTICONVULSANTS, SEDATIVES, MUSCLE RELAXANTS HOFFMANN-LA ROCHE INC. (US) 1988-10-04 US disclosed
EP-0100906-B1 TRI- AND TETRACYCLIC IMIDAZO(1,5-A)(1,4)BENZODIAZEPIN-1-CARBOXYLIC-ACID DERIVATIVES F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1987-05-13 EP disclosed
EP-0150040-A2 Imidazodiazepine derivatives F. HOFFMANN-LA ROCHE AG (CH) 1985-07-31 EP disclosed
EP-0100906-A2 Tri- and tetracyclic imidazo(1,5-a)(1,4)benzodiazepin-1-carboxylic-acid derivatives F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1984-02-22 EP disclosed
US-4352817-A ANTIDOTE FOR TRANQUILLIZING EFFECTS OF 1,4-BENZODIAZEPINES HOFFMANN-LA ROCHE INC. (US) 1982-10-05 US disclosed
US-4352818-A ANTIDOTES FOR INTOXICATION CAUSED BY 1,4-BENZODIAZEPINE TRANQUILIZERS HOFFMANN-LA ROCHE INC. (US) 1982-10-05 US disclosed
EP-0059390-A1 Imidazodiazepines, intermediate products and process for their preparation, and medicines containing them F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1982-09-08 EP disclosed